TickerTry: NVDA · AAPL · PLTR · NFLX

MapLight Therapeutics, Inc.

MLPT

Form 4 filings and STOCK Act disclosures for MapLight Therapeutics, Inc..

55
ROUTINE
Current InsiderScore
Corp · 90d
5
5 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Section 01

Recent Form 4 filings

6 filings on file
DateInsiderRoleActionSharesPriceValueScore
Aug 14Catalyst4, Inc.Buy4,400,000$11.38+$50.07M55
Jul 30Catalyst4, Inc.Buy1,000,000$13.00+$13.00M52
Jul 29Catalyst4, Inc.Buy3,000$12.63+$38K35
Jul 28Catalyst4, Inc.Buy65,137$11.69+$761K43
Jul 28Catalyst4, Inc.Buy141,088$10.74+$1.52M46
Oct 28Catalyst4, Inc.Buy5,441,176$17.00+$92.50M59
Section 02

Recent STOCK Act disclosures

No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03

InsiderScore history

Rolling 12 months · peak score per month
75 · STRONG60 · NOTABLE40 · ROUTINE
SepOctNovDecJanFebMarAprMayJunJulAug
/to search